Drone delivering gene therapies Competitors of Samsung Biologics, Swiss Lonza and Chinese Wuxi Biologics ... While there are no commercial products yet, significant capital has already been invested ...

Lonza to buy U.S. biologics site from Roche for $1.2B SA NewsWed, Mar. 20, 2024 6 Comments Lonza Group AG (LZAGY) Q4 2023 Earnings Call Transcript SA Transcripts Fri, Jan. 26, 2024 ...

The Global Primary Cell Culture Market is expected to grow significantly by 2030, fuelled by breakthroughs in the field of cell biology, regenerative medicine, and the development of personalized ...

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia ...

The real-world evidence solutions market is largely driven by the increasing prevalence of chronic diseases and their impact on real-world healthcare ...

The global modified release formulations market is set for continued expansion between 2025 and 2035, with its size projected to rise from USD 282.1 billion to approximately USD 524.7 billion, ...

Specific Biologics also extends its sincere gratitude to Dr. Steven Kanner for his dedicated service on the Board and guidance during a critical phase of the company's development.

See the latest Lonza Group Ltd stock price (LONN:XSWX), related news, valuation, dividends and more to help you make your investing decisions.